Tomoyuki Kawamura

6PUBLICATIONS
35CO-AUTHORS
Disease surveillancePharmacogenomicsTraditional Chinese medicine and treatmentsAutoimmunityImmunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 19, 2026
Observational study of the relationship between the use of real-time continuous glucose monitoring and glycemic control in patients with diabetes in Japan: the REALJ study.

|Nov 18, 2025
Diabetic Ketoacidosis and Severe Hypoglycemia Risks with Ipragliflozin/Insulin Versus Insulin in Type 1 Diabetes: A Japanese Real-World Database Study.

Tomoyuki Kawamura, Takumi Lee, Mami Shintani-Tachi

|Jun 26, 2025
Adjunct Therapy with Ipragliflozin Exerts Limited Effects on Kidney Protection in Type 1 Diabetes: A Retrospective Study Conducted at 25 Centers in Japan (IPRA-CKD).

Yuta Nakamura, Ichiro Horie, Hiroshi Yano

|Jul 23, 2020
Different interaction of onset age and duration of type 1 diabetes on the dynamics of autoantibodies to insulinoma-associated antigen-2 and zinc transporter 8.

Eiji Kawasaki, Yoichi Oikawa, Akira Okada

|Mar 17, 2020
Zinc transporter 8 autoantibodies complement glutamic acid decarboxylase and insulinoma-associated antigen-2 autoantibodies in the identification and characterization of Japanese type 1 diabetes.

Eiji Kawasaki, Yoichi Oikawa, Akira Okada

|Nov 23, 2019
Increased diagnosis of autoimmune childhood-onset Japanese type 1 diabetes using a new glutamic acid decarboxylase antibody enzyme-linked immunosorbent assay kit, compared with a previously used glutamic acid decarboxylase antibody radioimmunoassay kit.

Shigetaka Sugihara, Ichiro Yokota, Tokuo Mukai

Pageof 1

Frequent Collaborators

3 joint publications

Eiji Kawasaki

3 joint publications

Junnosuke Miura

2 joint publications

Tatsuhiko Urakami

2 joint publications

Yoichi Oikawa